Evidence map›Paper›PMID 25552927›Full record

ReviewInternational journal of biological sciences2015

Epithelial cell polarity determinant CRB3 in cancer development.

Pingping Li, Xiaona Mao, Yu Ren, Peijun Liu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. High expression of DLG3 is associated with decreased survival from breast cancer.Clinical and experimental pharmacology & physiology · 2019
    Article
  8. Cell Junctions in Hippo Signaling.Cold Spring Harbor perspectives in biology · 2018
    Review
  9. Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pingping Li1. Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University.
Xiaona Mao1. Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University.
Yu Ren2. Department of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University.
Peijun Liu1. Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University.
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell polarity, which is defined as asymmetry in cell shape, organelle distribution and cell function, is essential in numerous biological processes, including cell growth, cell migration and invasion, molecular transport, and cell fate. Epithelial cell polarity is mainly regulated by three conserved polarity protein complexes, the Crumbs (CRB) complex, partitioning defective (PAR) complex and Scribble (SCRIB) complex. Research evidence has indicated that dysregulation of cell polarity proteins may play an important role in cancer development. Crumbs homolog 3 (CRB3), a member of the CRB complex, may act as a cancer suppressor in mouse kidney epithelium and mouse mammary epithelium. In this review, we focus on the current data available on the roles of CRB3 in cancer development.

Indexed as

AnimalsCarcinogenesisCell PolarityEpithelial CellsFemaleKidneyMammary Glands, AnimalMembrane GlycoproteinsMembrane ProteinsMiceMultiprotein ComplexesSignal TransductionCrb3 protein, mouseMembrane GlycoproteinsMembrane ProteinsMultiprotein Complexesapical-basal polaritycancerCRB3EMT

Identifiers

PMID25552927
PMCPMC4278252
OpenAlexW2018800888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.